Buprenorphine Update: Practical Applications & State of the Art Innovations in OBOT



Overview

Once registered, click on the Tests Tab, then Launch Video.  Note: Viewing of the videos can be completed in one sitting or you may stop and resume at a later time/date. Please make a note where you left off as you will need to advance to that point upon return.  The entire video must be watched in order to claim credit.

You do not have to complete all of the modules at one time. You can complete one, then return to watch other modules at another time. You must watch the module video in its entirety and complete the post-test (attestation) to receive credit.  Once you've viewed all of the modules, you will then need to click on the Tests tab again to complete the post-test (attestation), evaluation and credit claim.

Release Date: July 3, 2024
Expiration Date: July 2, 2027                         

Activity Description
Primary care clinicians, mental health and addiction treatment providers who prescribe buprenorphine are faced with the unique clinical challenge of providing daily doses of an opioid to patients with addictive disease. 1. There are challenging clinical issues involved: stabilization v. maintenance doses; treating opiate addicted patients who have concomitant chronic intractable pain; treating opiate addicted patients with co-morbid depressive or anxiety disorders or sleep disturbances; and management of opiate medication side-effects are just a few examples. 2. There are unique ethical issues involved: patient safety v. minimization of disruption to patient daily life and the obligation to the individual patient v. the obligation to the community well-being. 3. There are unique Patient-Doctor and Patient-Treatment Program issues: staff splitting by patients; appropriately supervising toxicology testing while maintaining dignity; patient confidentiality concerns v. the need to have data from other providers regarding patient stability; and issues about dose adjustment, level of supervision and documentation. 4. There are rapidly changing expectations and concerns from regulatory agencies that must be understood and integrated into an evolving standard of care, and documented during increasingly frequent site visits and chart audits. It is for these reasons that faculty from the CWRU School of Medicine Addiction Psychiatry and Addiction Medicine Fellowship Programs has developed this special buprenorphine update.

Course Agenda
Buprenorphine: From the Basics to the Finer Points (1.25 Hour Credit)
Theodore Parran, MD

Buprenorphine Legal and Documentation Update: Federal & State Regulations and the EMR (.50 Hour Credit)
Theodore Parran, MD

Buprenorphine: Harm Reduction v. Adjunct to Sobriety (.50 Hour Credit)
Theodore Parran, MD

Buprenorphine Delivery Systems (.50 Hour Credit)
William Goldman, DO

Emerging Pharmacology of Buprenorphine (.50 Hour Credit)
William Goldman, DO

Getting Started With Buprenorphine Prescribing (.75 Hour Credit)
Theodore Parran, MD

Toxicology Testing when Prescribing Buprenorphine (.50 Hour Credit)
Theodore Parran, MD

Difficult Conversations During OBOT (.50 Hour Credit)
Theodore Parran, MD

Minimizing Diversion While Prescribing Buprenorphine (.50 Hour Credit)
Theodore Parran, MD

“Knowing How To Land” Stopping Buprenorphine RX (.50 Hour Credit)
Theodore Parran, MD

Diagnosis and Management of Anxiety in the OBOT Patient (.75 Hour Credit)
Theodore Parran, MD

Buprenorphine, Chronic Pain and the Patient with Opioid Use Disorder (1.00 Hour Credit)
Theodore Parran, MD

Prescribing Buprenorphine: Summary (.25 Hour Credit)
Theodore Parran, MD

Planning Committee
Course Director
Theodore V. Parran, Jr., MD, FACP
Carter and Isabel Wong Professor of Medical Education
Case Western Reserve University School of Medicine
Dr. Parran, planner for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

Amy Ross Pisman
Director
Continuing Medical Education Program
Case Western Reserve University School of Medicine
Ms. Pisman, planner for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose

Faculty
Course Director
Theodore V. Parran, Jr., MD, FACP
Carter and Isabel Wong Professor of Medical Education
Case Western Reserve University School of Medicine
Dr. Parran, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

William Goldman, DO, Diplomate ABPM in Addiction Medicine, FABP
Medical Director, Silver Maple Recovery
Medical Director, Prosperity Haven
Addiction Medicine Provider, Ravenwood Health
Staff Physician, Glenbeigh Hospital
Dr. Goldman, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.


Date & Location
Wednesday, July 3, 2024, 8:00 AM - Friday, July 2, 2027, 4:45 PM, Other

Target Audience
Specialties - General Practice, Internal Medicine, Psychiatry

Objectives
After attending this course, participants will be able to:

  1. Describe the pharmacologic profiles of buprenorphine, other opioids, benzodiazepines, THC and psychostimulants with regards to their interaction with the addiction prone brain
  2. Identify approaches to effectively address anxiety / depression / chronic pain / insomnia in the context of OBOT
  3. Employ techniques relating to minimizing the diversion of buprenorphine including use of different delivery systems
  4. Discuss risk management, office documentation and best practice guidelines for buprenorphine prescribing as well as evolving and emerging State and Federal requirements
  5. Practice difficult conversations when maintaining boundaries and clinical expectations in the OBOT clinic
  6. Compare and contrast “harm reduction” with “adjunct to sobriety” OBOT treatment approaches

Registration

$150

Resident/Fellow: Reduced $75 with Promo Code (Send letter from Program Director documenting residency status to [email protected] and a code will be emailed to you)


Accreditation

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this enduring material for a maximum of 8.0 AMA PRA Category 1™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Credits
AMA PRA Category 1 Credits™ (8.00 hours), Non-Physician Attendance (8.00 hours)